Product Code: PM1376
The global proteomics market size is expected to reach USD 90.83 billion by 2034, according to a new study by Polaris Market Research. The report "Proteomics Market Size, Share, Trends, Industry Analysis Report: By Product Type (Instruments, Reagents & Consumables, and Services), Application, Technology, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The proteomics market is centered around the comprehensive analysis of proteins, encompassing their structures, functions, interactions, and modifications within biological systems. This field plays a pivotal role in unraveling the complexities of cellular processes and understanding the molecular basis of diseases. By identifying and quantifying the entire set of proteins expressed by an organism, tissue, or cell at a specific time, proteomics provides crucial insights that are essential for advancements in various life science disciplines. The market's scope includes a wide array of tools, technologies, and services utilized in protein research and its diverse applications.
The proteomics market growth is driven by several key factors. The increasing focus on personalized medicine necessitates a deeper understanding of individual protein profiles to tailor treatments effectively. The pharmaceutical and biotechnology industries heavily rely on proteomics for drug target identification, biomarker discovery, and the development of novel therapeutics.
Technological advancements in analytical instruments, such as mass spectrometry and chromatography, along with sophisticated bioinformatics software, are enhancing the capabilities and efficiency of proteomic analyses. Furthermore, growing investments in research and development activities across academic institutions, government bodies, and private organizations continue to fuel the proteomics market expansion and innovation.
Proteomics Market Report Highlights
By product type, the reagents & consumables segment holds the largest proteomics market share due to the fundamental and continuous need for these products in proteomic experiments across all research and application areas globally. This consistent demand, driven by the ongoing nature of proteomic analysis, establishes its leading position in the product type segmentation.
By application, the drug discovery segment accounts for the largest market share. This is primarily because of the extensive application of proteomics in identifying potential drug targets and understanding disease mechanisms, which are critical steps in the heavily invested pharmaceutical research and development pipelines worldwide.
By technology, the spectroscopy segment commands the largest market share, largely due to the widespread and crucial role of mass spectrometry techniques in protein identification and quantification. Its versatility and essentiality in various proteomic workflows across different regions solidify its dominance in the technology segmentation.
By region, North America holds the largest share of the proteomics market revenue. The Asia Pacific market is projected to exhibit the highest growth rate during the forecast period.
A few major players actively contributing to the market include Thermo Fisher Scientific Inc.; Danaher Corporation; Agilent Technologies, Inc.; Bruker Corporation; PerkinElmer, Inc.; Bio-Rad Laboratories, Inc.; QIAGEN N.V.; Waters Corporation; SCIEX (part of Danaher Corporation); and Merck KgaA. These entities offer a comprehensive range of products and services essential for proteomic research and applications.
Polaris Market Research has segmented the market report on the basis of product type, application, technology, and region:
By Product Type Outlook (Revenue-USD Billion, 2020-2034)
Instruments
Protein Microarray
Spectrometry
Mass Spectrometry
NMR Spectroscopy
Chromatography
HPLC Systems
Ion Chromatography
Affinity Chromatography
Supercritical Fluid Chromatography
Electrophoresis
Gel Electrophoresis
Capillary Electrophoresis
Surface Plasmon Resonance
X-ray Crystallography
Protein Fractionation Systems
Reagents & Consumables
Microarray
Spectroscopy
X-ray Crystallography
Chromatography
Electrophoresis
Immunoassay
Protein Fractionation Reagents
Services
By Application Outlook (Revenue-USD Billion, 2020-2034)
Drug Discovery
Clinical Diagnosis
Molecular Medicine
Others
By Technology Outlook (Revenue-USD Billion, 2020-2034)
Microarray Instruments
X-Ray Crystallography
Spectroscopy
Chromatography
Protein Fractionation Systems
Electrophoresis
Surface Plasma Resonance (SPR) Systems
By Regional Outlook (Revenue-USD Billion, 2020-2034)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of the Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source
4. Global Proteomics Market Insights
- 4.1. Proteomics Market - Market Snapshot
- 4.2. Proteomics Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing Focus on Personalized Medicine
- 4.2.1.2. Advancements in Drug Discovery and Development
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High cost of proteomics instruments and reagents
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Proteomics Market Application Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Proteomics Market, by Product Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Proteomics Market, by Product Type, 2020-2034 (USD Billion)
- 5.3. Instruments
- 5.3.1. Global Proteomics Market, by Instruments, by Region, 2020-2034 (USD Billion)
- 5.3.2. Protein Microarray
- 5.3.3. Spectrometry
- 5.3.3.1. Mass Spectrometry
- 5.3.3.2. NMR Spectroscopy
- 5.3.4. Chromatography
- 5.3.4.1. HPLC Systems
- 5.3.4.2. Ion Chromatography
- 5.3.4.3. Affinity Chromatography
- 5.3.4.4. Supercritical Fluid Chromatography
- 5.3.5. Electrophoresis
- 5.3.5.1. Gel Electrophoresis
- 5.3.5.2. Capillary Electrophoresis
- 5.3.6. Surface Plasmon Resonance
- 5.3.7. X-ray Crystallography
- 5.3.8. Protein Fractionation Systems
- 5.4. Reagents & Consumables
- 5.4.1. Global Proteomics Market, by Reagents & Consumables, by Region, 2020-2034 (USD Billion)
- 5.4.2. Microarray
- 5.4.3. Spectroscopy
- 5.4.4. X-ray Crystallography
- 5.4.5. Chromatography
- 5.4.6. Electrophoresis
- 5.4.7. Immunoassay
- 5.4.8. Protein Fractionation Reagents
- 5.5. Services
- 5.5.1. Global Proteomics Market, by Services, by Region, 2020-2034 (USD Billion)
6. Global Proteomics Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Proteomics Market, by Application, 2020-2034 (USD Billion)
- 6.3. Drug Discovery
- 6.3.1. Global Proteomics Market, by Drug Discovery, by Region, 2020-2034 (USD Billion)
- 6.4. Clinical Diagnosis
- 6.4.1. Global Proteomics Market, by Clinical Diagnosis, by Region, 2020-2034 (USD Billion)
- 6.5. Molecular Medicine
- 6.5.1. Global Proteomics Market, by Molecular Medicine, by Region, 2020-2034 (USD Billion)
- 6.6. Others
- 6.6.1. Global Proteomics Market, by Others, by Region, 2020-2034 (USD Billion)
7. Global Proteomics Market, by Technology
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Proteomics Market, by Technology, 2020-2034 (USD Billion)
- 7.3. Microarray Instruments
- 7.3.1. Global Proteomics Market, by Microarray Instruments, by Region, 2020-2034 (USD Billion)
- 7.4. X-Ray Crystallography
- 7.4.1. Global Proteomics Market, by X-Ray Crystallography, by Region, 2020-2034 (USD Billion)
- 7.5. Spectroscopy
- 7.5.1. Global Proteomics Market, by Spectroscopy, by Region, 2020-2034 (USD Billion)
- 7.6. Chromatography
- 7.6.1. Global Proteomics Market, by Chromatography, by Region, 2020-2034 (USD Billion)
- 7.7. Protein Fractionation Systems
- 7.7.1. Global Proteomics Market, by Protein Fractionation Systems, by Region, 2020-2034 (USD Billion)
- 7.8. Electrophoresis
- 7.8.1. Global Proteomics Market, by Electrophoresis, by Region, 2020-2034 (USD Billion)
- 7.9. Surface Plasma Resonance (SPR) Systems
- 7.9.1. Global Proteomics Market, by Surface Plasma Resonance (SPR) Systems, by Region, 2020-2034 (USD Billion)
8. Global Proteomics Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Proteomics Market Assessment, By Geography, 2020-2034 (USD Billion)
- 8.3. Proteomics Market - North America
- 8.3.1. North America: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
- 8.3.2. North America: Proteomics Market, by Application, 2020-2034 (USD Billion)
- 8.3.3. North America: Proteomics Market, by Technology, 2020-2034 (USD Billion)
- 8.3.4. Proteomics Market - U.S.
- 8.3.4.1. U.S.: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
- 8.3.4.2. U.S.: Proteomics Market, by Application, 2020-2034 (USD Billion)
- 8.3.4.3. U.S.: Proteomics Market, by Technology, 2020-2034 (USD Billion)
- 8.3.5. Proteomics Market - Canada
- 8.3.5.1. Canada: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
- 8.3.5.2. Canada: Proteomics Market, by Application, 2020-2034 (USD Billion)
- 8.3.5.3. Canada: Proteomics Market, by Technology, 2020-2034 (USD Billion)
- 8.4. Proteomics Market - Europe
- 8.4.1. Europe: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
- 8.4.2. Europe: Proteomics Market, by Application, 2020-2034 (USD Billion)
- 8.4.3. Europe: Proteomics Market, by Technology, 2020-2034 (USD Billion)
- 8.4.4. Proteomics Market - UK
- 8.4.4.1. UK: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
- 8.4.4.2. UK: Proteomics Market, by Application, 2020-2034 (USD Billion)
- 8.4.4.3. UK: Proteomics Market, by Technology, 2020-2034 (USD Billion)
- 8.4.5. Proteomics Market - France
- 8.4.5.1. France: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
- 8.4.5.2. France: Proteomics Market, by Application, 2020-2034 (USD Billion)
- 8.4.5.3. France: Proteomics Market, by Technology, 2020-2034 (USD Billion)
- 8.4.6. Proteomics Market - Germany
- 8.4.6.1. Germany: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
- 8.4.6.2. Germany: Proteomics Market, by Application, 2020-2034 (USD Billion)
- 8.4.6.3. Germany: Proteomics Market, by Technology, 2020-2034 (USD Billion)
- 8.4.7. Proteomics Market - Italy
- 8.4.7.1. Italy: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
- 8.4.7.2. Italy: Proteomics Market, by Application, 2020-2034 (USD Billion)
- 8.4.7.3. Italy: Proteomics Market, by Technology, 2020-2034 (USD Billion)
- 8.4.8. Proteomics Market - Spain
- 8.4.8.1. Spain: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
- 8.4.8.2. Spain: Proteomics Market, by Application, 2020-2034 (USD Billion)
- 8.4.8.3. Spain: Proteomics Market, by Technology, 2020-2034 (USD Billion)
- 8.4.9. Proteomics Market - Netherlands
- 8.4.9.1. Netherlands: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
- 8.4.9.2. Netherlands: Proteomics Market, by Application, 2020-2034 (USD Billion)
- 8.4.9.3. Netherlands: Proteomics Market, by Technology, 2020-2034 (USD Billion)
- 8.4.10. Proteomics Market - Russia
- 8.4.10.1. Russia: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
- 8.4.10.2. Russia: Proteomics Market, by Application, 2020-2034 (USD Billion)
- 8.4.10.3. Russia: Proteomics Market, by Technology, 2020-2034 (USD Billion)
- 8.4.11. Proteomics Market - Rest of Europe
- 8.4.11.1. Rest of Europe: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
- 8.4.11.2. Rest of Europe: Proteomics Market, by Application, 2020-2034 (USD Billion)
- 8.4.11.3. Rest of Europe: Proteomics Market, by Technology, 2020-2034 (USD Billion)
- 8.5. Proteomics Market - Asia Pacific
- 8.5.1. Asia Pacific: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Proteomics Market, by Application, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Proteomics Market, by Technology, 2020-2034 (USD Billion)
- 8.5.4. Proteomics Market - China
- 8.5.4.1. China: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
- 8.5.4.2. China: Proteomics Market, by Application, 2020-2034 (USD Billion)
- 8.5.4.3. China: Proteomics Market, by Technology, 2020-2034 (USD Billion)
- 8.5.5. Proteomics Market - India
- 8.5.5.1. India: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
- 8.5.5.2. India: Proteomics Market, by Application, 2020-2034 (USD Billion)
- 8.5.5.3. India: Proteomics Market, by Technology, 2020-2034 (USD Billion)
- 8.5.6. Proteomics Market - Malaysia
- 8.5.6.1. Malaysia: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
- 8.5.6.2. Malaysia: Proteomics Market, by Application, 2020-2034 (USD Billion)
- 8.5.6.3. Malaysia: Proteomics Market, by Technology, 2020-2034 (USD Billion)
- 8.5.7. Proteomics Market - Japan
- 8.5.7.1. Japan: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
- 8.5.7.2. Japan: Proteomics Market, by Application, 2020-2034 (USD Billion)
- 8.5.7.3. Japan: Proteomics Market, by Technology, 2020-2034 (USD Billion)
- 8.5.8. Proteomics Market - Indonesia
- 8.5.8.1. Indonesia: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
- 8.5.8.2. Indonesia: Proteomics Market, by Application, 2020-2034 (USD Billion)
- 8.5.8.3. Indonesia: Proteomics Market, by Technology, 2020-2034 (USD Billion)
- 8.5.9. Proteomics Market - South Korea
- 8.5.9.1. South Korea: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
- 8.5.9.2. South Korea: Proteomics Market, by Application, 2020-2034 (USD Billion)
- 8.5.9.3. South Korea: Proteomics Market, by Technology, 2020-2034 (USD Billion)
- 8.5.10. Proteomics Market - Australia
- 8.5.10.1. Australia: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
- 8.5.10.2. Australia: Proteomics Market, by Application, 2020-2034 (USD Billion)
- 8.5.10.3. Australia: Proteomics Market, by Technology, 2020-2034 (USD Billion)
- 8.5.11. Proteomics Market - Rest of Asia Pacific
- 8.5.11.1. Rest of Asia Pacific: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
- 8.5.11.2. Rest of Asia Pacific: Proteomics Market, by Application, 2020-2034 (USD Billion)
- 8.5.11.3. Rest of Asia Pacific: Proteomics Market, by Technology, 2020-2034 (USD Billion)
- 8.6. Proteomics Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Proteomics Market, by Application, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Proteomics Market, by Technology, 2020-2034 (USD Billion)
- 8.6.4. Proteomics Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
- 8.6.4.2. Saudi Arabia: Proteomics Market, by Application, 2020-2034 (USD Billion)
- 8.6.4.3. Saudi Arabia: Proteomics Market, by Technology, 2020-2034 (USD Billion)
- 8.6.5. Proteomics Market - UAE
- 8.6.5.1. UAE: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
- 8.6.5.2. UAE: Proteomics Market, by Application, 2020-2034 (USD Billion)
- 8.6.5.3. UAE: Proteomics Market, by Technology, 2020-2034 (USD Billion)
- 8.6.6. Proteomics Market - Israel
- 8.6.6.1. Israel: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
- 8.6.6.2. Israel: Proteomics Market, by Application, 2020-2034 (USD Billion)
- 8.6.6.3. Israel: Proteomics Market, by Technology, 2020-2034 (USD Billion)
- 8.6.7. Proteomics Market - South Africa
- 8.6.7.1. South Africa: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
- 8.6.7.2. South Africa: Proteomics Market, by Application, 2020-2034 (USD Billion)
- 8.6.7.3. South Africa: Proteomics Market, by Technology, 2020-2034 (USD Billion)
- 8.6.8. Proteomics Market - Rest of Middle East & Africa
- 8.6.8.1. Rest of Middle East & Africa: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
- 8.6.8.2. Rest of Middle East & Africa: Proteomics Market, by Application, 2020-2034 (USD Billion)
- 8.6.8.3. Rest of Middle East & Africa: Proteomics Market, by Technology, 2020-2034 (USD Billion)
- 8.7. Proteomics Market - Latin America
- 8.7.1. Latin America: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Proteomics Market, by Application, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Proteomics Market, by Technology, 2020-2034 (USD Billion)
- 8.7.4. Proteomics Market - Mexico
- 8.7.4.1. Mexico: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
- 8.7.4.2. Mexico: Proteomics Market, by Application, 2020-2034 (USD Billion)
- 8.7.4.3. Mexico: Proteomics Market, by Technology, 2020-2034 (USD Billion)
- 8.7.5. Proteomics Market - Brazil
- 8.7.5.1. Brazil: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
- 8.7.5.2. Brazil: Proteomics Market, by Application, 2020-2034 (USD Billion)
- 8.7.5.3. Brazil: Proteomics Market, by Technology, 2020-2034 (USD Billion)
- 8.7.6. Proteomics Market - Argentina
- 8.7.6.1. Argentina: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
- 8.7.6.2. Argentina: Proteomics Market, by Application, 2020-2034 (USD Billion)
- 8.7.6.3. Argentina: Proteomics Market, by Technology, 2020-2034 (USD Billion)
- 8.7.7. Proteomics Market - Rest of Latin America
- 8.7.7.1. Rest of Latin America: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
- 8.7.7.2. Rest of Latin America: Proteomics Market, by Application, 2020-2034 (USD Billion)
- 8.7.7.3. Rest of Latin America: Proteomics Market, by Technology, 2020-2034 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Agilent Technologies, Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Bio-Rad Laboratories, Inc
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development .
- 10.3. Bruker Corporation
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Danaher Corporation
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Merck KGaA
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. PerkinElmer, Inc.
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. QIAGEN N.V.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. SCIEX
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Thermo Fisher Scientific Inc.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Waters Corporation
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development